Erudio Healtherudio.com
Drug
durvalumab
1 HCP commentary report on clinical trials studying durvalumab. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Statements | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| SKYSCRAPER-03 NCT04513925 · Hoffmann-La Roche | locally advanced, unresectable stage III NSCLC | Phase 3 | 122 | 39 | Focused | Oct 31, 2026 | Preview |